SUBLICENSE AGREEMENTSublicense Agreement • March 21st, 2013 • Tg Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This SUBLICENSE AGREEMENT (this “Agreement”) is entered into as of November 13, 2012 (the “Effective Date”) by and between TG Biologics, Inc., a Delaware corporation with a principal place of business at 787 Seventh Avenue, 48th Floor, New York, New York 10019 (“TG” or SUBLICENSOR”) and Ildong Pharmaceutical Co. Ltd., a Korean limited company with a principal place of business at 60 Yangjae-dong, Seocho-ku, Seoul 137-733 KOREA (“ILDONG”). Each of ILDONG and SUBLICENSOR is sometimes referred to individually herein as a “Party” and collectively as the “Parties.”
